GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Pfizer (BUE:PFE) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Mar. 28, 2025)


View and export this data going back to . Start your Free Trial

What is Pfizer Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Pfizer's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Pfizer's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, Pfizer's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Pfizer's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Pfizer  (BUE:PFE) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Pfizer Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Pfizer's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.